1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NURIX THERAPEUTICS INC
Nurix Therapeutics Inc XNAS: NRIX

Nurix Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disor...

Read More
9.91 0.79 (8.66%)
66.47% Fall from 52W High
831.9K
XNAS Volume

XNAS 05 Sep, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Nurix Therapeutics Inc is on 16 Sep 2025 for the purpose of Stifel Virtual Immunology & Inflammation Forum See details
Durability score
Low Financial Strength
22.2 / 100
Valuation Score
Expensive Valuation
17.5 / 100
Momentum Score
Technically Neutral
36.6 / 100
Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM
Analyst Price Target
30
1Yr Price target upside is 201%
18 analysts

13

S

10

W

2

O

1

T

SWOT Analysis

Nurix Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..